News Column

KYTHERA BIOPHARMACEUTICALS INC FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders

June 9, 2014

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 5, 2014, KYTHERA Biopharmaceuticals, Inc. (the "Company") held its Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, the Company's stockholders voted on two proposals, each of which is described in more detail in the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 17, 2014. Only stockholders of record as of the close of business on April 16, 2014, the record date for the Annual Meeting, were entitled to vote at the Annual Meeting. As of the record date, 22,656,603 shares of the Company's common stock were outstanding and entitled to vote at the Annual Meeting. The tabulation of the stockholder votes on each proposal brought before the Annual Meeting is as follows:

Proposal 1. The election of three directors to hold office until the 2017 annual meeting of stockholders or until their respective successor is elected:

Broker Nominee Votes For Votes Withheld Non-Votes F. Michael Ball 16,134,453 589,124 2,778,160

Nathaniel David, Ph.D. 13,806,988 2,916,589 2,778,160

Robert T. Nelsen 16,539,850 183,727 2,778,160

Proposal 2. The ratification of the selection, by the Audit Committee of the Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2014:

Votes For Votes Against Abstentions 19,495,373 6,348 16

As a routine proposal under applicable rules, no broker non-votes were recorded in connection with this proposal.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters